These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 87687

  • 21. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S.
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [Abstract] [Full Text] [Related]

  • 22. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE.
    Clin Infect Dis; 2004 Jun 15; 38(12):1780-3. PubMed ID: 15227627
    [Abstract] [Full Text] [Related]

  • 23. Rubella-vaccinated students. Follow-up in a public school system.
    Schiff GM, Rauh JL, Young B, Trimble S, Rotte T, Schiff BE.
    JAMA; 1978 Dec 08; 240(24):2635-7. PubMed ID: 712979
    [Abstract] [Full Text] [Related]

  • 24. Rubella epidemiology in South East England.
    Nokes DJ, Anderson RM, Anderson MJ.
    J Hyg (Lond); 1986 Apr 08; 96(2):291-304. PubMed ID: 3701043
    [Abstract] [Full Text] [Related]

  • 25. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
    Lawless MR, Abramson JS, Harlan JE, Kelsey DS.
    Pediatrics; 1980 Jun 08; 65(6):1086-9. PubMed ID: 7375231
    [Abstract] [Full Text] [Related]

  • 26. Seroepidemiology of rubella in northern Greece.
    Gioula G, Diza-Mataftsi E, Alexiou-Daniel S, Kyriazopoulou-Dalaina V.
    Eur J Clin Microbiol Infect Dis; 2004 Aug 08; 23(8):631-3. PubMed ID: 15243817
    [Abstract] [Full Text] [Related]

  • 27. Postinfection and postvaccination antirubella immunity.
    Kańtoch M, Imbs D.
    Acta Virol; 1986 Sep 08; 30(5):381-9. PubMed ID: 2878585
    [Abstract] [Full Text] [Related]

  • 28. [Epidemiologic situation of rubella in Italy 20 years after the introduction of the vaccine].
    Galli MG.
    Ann Ig; 1989 Sep 08; 1(1-2):247-54. PubMed ID: 2483071
    [Abstract] [Full Text] [Related]

  • 29. [The rubella immunity survey of unmarried school-aged women in Taipei and feasibility study of rubella vaccination].
    Wu LC, Yen MH, Ng HT, Yuan FJ.
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Sep 08; 40(3):309-16. PubMed ID: 3502849
    [No Abstract] [Full Text] [Related]

  • 30. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126
    [Abstract] [Full Text] [Related]

  • 31. Humoral immune response after primary rubella virus infection and after vaccination.
    Vauloup-Fellous C, Grangeot-Keros L.
    Clin Vaccine Immunol; 2007 May 07; 14(5):644-7. PubMed ID: 17344342
    [Abstract] [Full Text] [Related]

  • 32. Rubella Seroprevalence among the General Population in Dongguan, China.
    Lin W, Wang D, Xiong Y, Tang H, Liao Z, Ni J.
    Jpn J Infect Dis; 2015 May 07; 68(3):192-5. PubMed ID: 25672349
    [Abstract] [Full Text] [Related]

  • 33. The rubella story, 1881-1985.
    Horstmann DM.
    S Afr Med J; 1986 Oct 11; Suppl():60-3. PubMed ID: 3535122
    [No Abstract] [Full Text] [Related]

  • 34. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM, Grenfell BT.
    J Hyg (Lond); 1986 Apr 11; 96(2):305-33. PubMed ID: 3701044
    [Abstract] [Full Text] [Related]

  • 35. Vaccines to prevent rubella.
    André FE, Florent G, du Pan RM.
    Lancet; 1980 Mar 22; 1(8169):657-8. PubMed ID: 6102664
    [No Abstract] [Full Text] [Related]

  • 36. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains].
    Zou J, Senecal J, Morvan A, Roussey A.
    Ann Pediatr (Paris); 1976 Feb 02; 23(2):111-8. PubMed ID: 16104238
    [No Abstract] [Full Text] [Related]

  • 37. [Rubella in Russia: the detection of congenital rubella and the vaccination strategy and procedures].
    Semerikov VV, Popov VF, Sedel'nikova TA, Iunasova TN, Kaplunova OP, Kolotov ME, Nikolova IV.
    Zh Mikrobiol Epidemiol Immunobiol; 1998 Feb 02; (1):46-9. PubMed ID: 9532685
    [Abstract] [Full Text] [Related]

  • 38. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR, Schneider F, Muller CP.
    Vaccine; 2006 Mar 24; 24(14):2594-601. PubMed ID: 16427163
    [Abstract] [Full Text] [Related]

  • 39. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M, Senn N, Clements CJ, Hobday L, Cowie B, Kurubi J, Kevin A, Siba P, Reeder JC, Morgan C.
    Vaccine; 2012 Dec 14; 30(52):7506-12. PubMed ID: 23103194
    [Abstract] [Full Text] [Related]

  • 40. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes.
    Kakoulidou M, Forsgren M, Lewensohn-Fuchs I, Johansen K.
    Vaccine; 2010 Jan 22; 28(4):1002-7. PubMed ID: 19925909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.